Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition

MeSH terms

• Aged
• Angioplasty, Balloon, Coronary*
• Anticoagulants / administration & dosage*
• Anticoagulants / adverse effects
• Anticoagulants / therapeutic use*
• Blood Vessel Prosthesis Implantation*
• Cardiovascular Diseases / drug therapy*
• Cardiovascular Diseases / mortality
• Cardiovascular Diseases / surgery*
• Drug Therapy, Combination
• Female
• Follow-Up Studies
• Hirudins / administration & dosage*
• Hirudins / adverse effects
• Hirudins / analogs & derivatives*
• Humans
• Male
• Middle Aged
• Outcome Assessment, Health Care
• Peptide Fragments / administration & dosage*
• Peptide Fragments / adverse effects
• Peptide Fragments / therapeutic use*
• Platelet Glycoprotein GPIIb-IIIa Complex / administration & dosage
• Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
• Platelet Glycoprotein GPIIb-IIIa Complex / therapeutic use*
• Recombinant Proteins / administration & dosage*
• Recombinant Proteins / adverse effects
• Recombinant Proteins / therapeutic use*
• Stents*
• Survival Rate